The Digital Marshmallow Test (DMT) Diagnostic and Monitoring Mobile Health App for Impulsive Behavior: Development and Validation Study.
ResearchKit
active task
ecological momentary assessment
impulse control
impulsivity
mHealth
mobile health
self-control
self-regulation
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
22 01 2021
22 01 2021
Historique:
received:
15
10
2020
accepted:
07
12
2020
revised:
29
11
2020
entrez:
22
1
2021
pubmed:
23
1
2021
medline:
9
3
2021
Statut:
epublish
Résumé
The classic Marshmallow Test, where children were offered a choice between one small but immediate reward (eg, one marshmallow) or a larger reward (eg, two marshmallows) if they waited for a period of time, instigated a wealth of research on the relationships among impulsive responding, self-regulation, and clinical and life outcomes. Impulsivity is a hallmark feature of self-regulation failures that lead to poor health decisions and outcomes, making understanding and treating impulsivity one of the most important constructs to tackle in building a culture of health. Despite a large literature base, impulsivity measurement remains difficult due to the multidimensional nature of the construct and limited methods of assessment in daily life. Mobile devices and the rise of mobile health (mHealth) have changed our ability to assess and intervene with individuals remotely, providing an avenue for ambulatory diagnostic testing and interventions. Longitudinal studies with mobile devices can further help to understand impulsive behaviors and variation in state impulsivity in daily life. The aim of this study was to develop and validate an impulsivity mHealth diagnostics and monitoring app called Digital Marshmallow Test (DMT) using both the Apple and Android platforms for widespread dissemination to researchers, clinicians, and the general public. The DMT app was developed using Apple's ResearchKit (iOS) and Android's ResearchStack open source frameworks for developing health research study apps. The DMT app consists of three main modules: self-report, ecological momentary assessment, and active behavioral and cognitive tasks. We conducted a study with a 21-day assessment period (N=116 participants) to validate the novel measures of the DMT app. We used a semantic differential scale to develop self-report trait and momentary state measures of impulsivity as part of the DMT app. We identified three state factors (inefficient, thrill seeking, and intentional) that correlated highly with established measures of impulsivity. We further leveraged momentary semantic differential questions to examine intraindividual variability, the effect of daily life, and the contextual effect of mood on state impulsivity and daily impulsive behaviors. Our results indicated validation of the self-report sematic differential and related results, and of the mobile behavioral tasks, including the Balloon Analogue Risk Task and Go-No-Go task, with relatively low validity of the mobile Delay Discounting task. We discuss the design implications of these results to mHealth research. This study demonstrates the potential for assessing different facets of trait and state impulsivity during everyday life and in clinical settings using the DMT mobile app. The DMT app can be further used to enhance our understanding of the individual facets that underlie impulsive behaviors, as well as providing a promising avenue for digital interventions. ClinicalTrials.gov NCT03006653; https://www.clinicaltrials.gov/ct2/show/NCT03006653.
Sections du résumé
BACKGROUND
The classic Marshmallow Test, where children were offered a choice between one small but immediate reward (eg, one marshmallow) or a larger reward (eg, two marshmallows) if they waited for a period of time, instigated a wealth of research on the relationships among impulsive responding, self-regulation, and clinical and life outcomes. Impulsivity is a hallmark feature of self-regulation failures that lead to poor health decisions and outcomes, making understanding and treating impulsivity one of the most important constructs to tackle in building a culture of health. Despite a large literature base, impulsivity measurement remains difficult due to the multidimensional nature of the construct and limited methods of assessment in daily life. Mobile devices and the rise of mobile health (mHealth) have changed our ability to assess and intervene with individuals remotely, providing an avenue for ambulatory diagnostic testing and interventions. Longitudinal studies with mobile devices can further help to understand impulsive behaviors and variation in state impulsivity in daily life.
OBJECTIVE
The aim of this study was to develop and validate an impulsivity mHealth diagnostics and monitoring app called Digital Marshmallow Test (DMT) using both the Apple and Android platforms for widespread dissemination to researchers, clinicians, and the general public.
METHODS
The DMT app was developed using Apple's ResearchKit (iOS) and Android's ResearchStack open source frameworks for developing health research study apps. The DMT app consists of three main modules: self-report, ecological momentary assessment, and active behavioral and cognitive tasks. We conducted a study with a 21-day assessment period (N=116 participants) to validate the novel measures of the DMT app.
RESULTS
We used a semantic differential scale to develop self-report trait and momentary state measures of impulsivity as part of the DMT app. We identified three state factors (inefficient, thrill seeking, and intentional) that correlated highly with established measures of impulsivity. We further leveraged momentary semantic differential questions to examine intraindividual variability, the effect of daily life, and the contextual effect of mood on state impulsivity and daily impulsive behaviors. Our results indicated validation of the self-report sematic differential and related results, and of the mobile behavioral tasks, including the Balloon Analogue Risk Task and Go-No-Go task, with relatively low validity of the mobile Delay Discounting task. We discuss the design implications of these results to mHealth research.
CONCLUSIONS
This study demonstrates the potential for assessing different facets of trait and state impulsivity during everyday life and in clinical settings using the DMT mobile app. The DMT app can be further used to enhance our understanding of the individual facets that underlie impulsive behaviors, as well as providing a promising avenue for digital interventions.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03006653; https://www.clinicaltrials.gov/ct2/show/NCT03006653.
Identifiants
pubmed: 33480854
pii: v9i1e25018
doi: 10.2196/25018
pmc: PMC7837672
doi:
Banques de données
ClinicalTrials.gov
['NCT03006653']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25018Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
©Michael Sobolev, Rachel Vitale, Hongyi Wen, James Kizer, Robert Leeman, J P Pollak, Amit Baumel, Nehal P Vadhan, Deborah Estrin, Frederick Muench. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 22.01.2021.
Références
Am J Prev Med. 2016 Nov;51(5):816-824
pubmed: 27745681
Am J Prev Med. 2013 Aug;45(2):228-36
pubmed: 23867031
NPJ Digit Med. 2020 Feb 17;3:21
pubmed: 32128451
Ann Behav Med. 2018 May 18;52(6):446-462
pubmed: 27663578
Diagnosis (Berl). 2018 Sep 25;5(3):95-105
pubmed: 30032130
J Exp Psychol Appl. 2002 Jun;8(2):75-84
pubmed: 12075692
Psychol Bull. 2020 Apr;146(4):324-354
pubmed: 31904248
Immunol Res. 2015 Dec;63(1-3):107-12
pubmed: 26467974
J R Soc Med. 2015 Aug;108(8):294-6
pubmed: 26268915
NPJ Digit Med. 2020 Jan 13;3:4
pubmed: 31970289
Assessment. 2021 Apr;28(3):796-812
pubmed: 32680433
Dev Psychol. 2018 Aug;54(8):1395-1407
pubmed: 29939038
Psychol Assess. 2015 Dec;27(4):1129-46
pubmed: 25822833
Ann Behav Med. 2020 Nov 1;54(11):805-826
pubmed: 32338719
J Affect Disord. 2020 Mar 15;265:314-324
pubmed: 32090755
J Pers. 2007 Aug;75(4):825-61
pubmed: 17576360
J Neurosci. 2003 Aug 27;23(21):7839-43
pubmed: 12944513
J Pers Soc Psychol. 2007 Jun;92(6):1087-101
pubmed: 17547490
Psychol Sci. 2018 Jul;29(7):1159-1177
pubmed: 29799765
Sci Data. 2016 Mar 03;3:160011
pubmed: 26938265
J Pers. 2018 Oct;86(5):841-852
pubmed: 29125631
Behav Processes. 2014 Sep;107:99-105
pubmed: 25139835
Psychol Rev. 2021 Mar;128(2):336-361
pubmed: 32969672
J Psychopathol Behav Assess. 2018 Mar;40(1):107-116
pubmed: 30505069
Int J Neurosci. 2007 Mar;117(3):359-68
pubmed: 17365120
Psychol Sci. 2006 Jun;17(6):478-84
pubmed: 16771797
Addiction. 2006 Sep;101(9):1323-32
pubmed: 16911732
BMC Med. 2019 Jul 17;17(1):133
pubmed: 31311528
J Adolesc. 2003 Aug;26(4):475-9
pubmed: 12887935
Psychol Sci. 2005 Dec;16(12):939-44
pubmed: 16313657
J Med Internet Res. 2017 Jun 29;19(6):e232
pubmed: 28663162
Exp Clin Psychopharmacol. 2009 Apr;17(2):113-21
pubmed: 19331488
J Exp Psychol Gen. 2018 Sep;147(9):1349-1381
pubmed: 30148386
Drug Alcohol Depend. 2017 Sep 1;178:408-416
pubmed: 28709080
Psychol Bull. 2017 Aug;143(8):868-902
pubmed: 28493725
J Vis Exp. 2016 Jan 09;(107):
pubmed: 26779747
Health Psychol Rev. 2020 Mar;14(1):6-42
pubmed: 31662031
Health Psychol. 2015 Dec;34S:1209-19
pubmed: 26651462
N Engl J Med. 2019 Sep 5;381(10):956-968
pubmed: 31483966
J Med Internet Res. 2020 Oct 29;22(10):e20631
pubmed: 33118946
Psychol Assess. 2014 Jun;26(2):339-49
pubmed: 24274047
JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186
pubmed: 31461131
Psychol Addict Behav. 2021 Mar;35(2):199-207
pubmed: 32914990
J Behav Ther Exp Psychiatry. 1994 Mar;25(1):49-59
pubmed: 7962581
Sci Adv. 2017 Oct 04;3(10):e1701381
pubmed: 28983511
Exp Clin Psychopharmacol. 2020 Apr 20;:
pubmed: 32309968
J Exp Anal Behav. 1999 Mar;71(2):121-43
pubmed: 10220927
Q J Exp Psychol. 1980 Feb;32(1):3-25
pubmed: 7367577
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5472-5477
pubmed: 30842284
Alcohol Clin Exp Res. 2018 Sep;42(9):1815-1822
pubmed: 29969149
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Nat Rev Neurosci. 2017 Feb 17;18(3):158-171
pubmed: 28209979
Am J Drug Alcohol Abuse. 2010 Sep;36(5):233-41
pubmed: 20560821
J Clin Psychol. 1988 Jan;44(1):33-6
pubmed: 3343359
Psychol Health. 2011 May;26(5):517-30
pubmed: 20945252
Am J Psychiatry. 2001 Nov;158(11):1783-93
pubmed: 11691682
Drug Alcohol Depend. 2019 Dec 1;205:107683
pubmed: 31704385
J Neurosci. 2004 Dec 8;24(49):11017-22
pubmed: 15590917
Int J Obes (Lond). 2019 Jun;43(6):1135-1146
pubmed: 30482934
Annu Rev Psychol. 2003;54:579-616
pubmed: 12499517
J Exp Psychol Gen. 2014 Apr;143(2):850-86
pubmed: 23957282
Psychol Med. 2019 Jan;49(2):190-199
pubmed: 30070191
Psychol Bull. 2014 Mar;140(2):374-408
pubmed: 24099400
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14998-5003
pubmed: 21876169
Science. 1989 May 26;244(4907):933-8
pubmed: 2658056
Pers Soc Psychol Rev. 2012 Feb;16(1):76-99
pubmed: 21878607
Behav Res Ther. 2007 May;45(5):1071-5
pubmed: 16828053
Front Psychol. 2017 Apr 12;8:557
pubmed: 28446889
Perspect Psychol Sci. 2007 Dec;2(4):313-45
pubmed: 26151971
Arch Neurol. 2010 May;67(5):589-95
pubmed: 20457959
Annu Rev Clin Psychol. 2008;4:1-32
pubmed: 18509902
Psychopharmacology (Berl). 2018 May;235(5):1487-1496
pubmed: 29497782